penicillamine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shome, R | 1 |
| Ghosh, SS | 1 |
1 other study available for penicillamine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Transferrin Coated d-penicillamine-Au-Cu Nanocluster PLGA Nanocomposite Reverses Hypoxia-Induced EMT and MDR of Triple-Negative Breast Cancers.
Topics: Apoptosis; beta Catenin; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; Copper; Down- | 2021 |